GIST Clinical Trials

 Page 1 of 2 | Next | Last

   
Phase 4

Intervention:  
Imatinib + Sunitinib + Regorafenib
Status:  
Recruiting
Phase 2

Intervention:  
AUY922
Status:  
Recruiting
Phase 2

Intervention:  
Sunitinib
Status:  
Recruiting
Phase 1

Intervention:  
HER-2 B Cell Peptide
Status:  
Recruiting
Phase 2

Intervention:  
MEK162 + BYL719
Status:  
Recruiting
Phase 1

Intervention:  
Dasatinib + Ipilimumab
Status:  
Recruiting
Phase 2

Intervention:  
Imatinib
Status:  
Recruiting
Phase 1

Intervention:  
Imatinib + Ipilimumab
Status:  
Recruiting
Phase 1

Intervention:  
Imatinib + MEK162
Status:  
Recruiting
Phase 1

Intervention:  
Sunitinib + Regorafenib
Status:  
Recruiting
Phase 1

Intervention:  
Nivolumab + BMS-986016
Status:  
Recruiting
Phase 2

Intervention:  
Palbociclib
Status:  
Recruiting
Phase 2

Intervention:  
LEE011
Status:  
Recruiting
Phase 1/2

Intervention:  
Imatinib + BGJ398
Status:  
Recruiting
Phase 1

Intervention:  
CB-839
Status:  
Recruiting
Phase 1

Intervention:  
Imatinib
Status:  
Recruiting
Phase 2

Intervention:  
CPI-613
Status:  
Recruiting
Phase

Intervention:  
Imatinib + Sunitinib + Regorafenib
Status:  
Recruiting
Phase 1

Intervention:  
PLX9486 + PLX3397
Status:  
Recruiting
Phase 2

Intervention:  
Cabozantinib
Status:  
Recruiting
Phase 1

Intervention:  
Cobimetinib + MPDL3280A
Status:  
Recruiting
Phase 2

Intervention:  
Imatinib + Regorafenib
Status:  
Recruiting
Phase 1

Intervention:  
PLX3397 + Pembrolizumab
Status:  
Recruiting
Phase 1/2

Intervention:  
PDR001
Status:  
Recruiting
Phase 1

Intervention:  
BLU-285
Status:  
Recruiting
Phase 1

Intervention:  
DCC-2618
Status:  
Recruiting
Phase 3

Intervention:  
Imatinib
Status:  
Recruiting
Phase 1

Intervention:  
KTN0158
Status:  
Recruiting
Phase 2

Intervention:  
Dabrafenib + Trametinib
Status:  
Recruiting
Phase 2

Intervention:  
Axitinib + Pembrolizumab
Status:  
Recruiting